Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1 2

Status

Completed 4Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4Thoracic 1Gynecologic 1Breast 1

Conditions

Colorectal Neoplasms 39Rectal Neoplasms 11Colonic Neoplasms 11Neoplasms 10Neoplasm Metastasis 9Stomach Neoplasms 4Ovarian Neoplasms 3Gastrointestinal Neoplasms 3Pancreatic Neoplasms 2Lung Neoplasms 2Adenocarcinoma 2Parkinson Disease 4, Autosomal Dominant Lewy Body 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myeloid, Acute 1Hematologic Neoplasms 1Exanthema 1Colorectal Cancer Metastatic 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Neuroendocrine 1Carcinoma, Basal Cell 1Carcinoma 1Breast Neoplasms 1Advanced Cancer 1

Interventions

Cisplatin 117Oxaliplatin 111Fluorouracil 100Capecitabine 90Docetaxel 69Leucovorin 60Irinotecan 57Paclitaxel 49S 1 (combination) 38pembrolizumab 35Trastuzumab 31Radiotherapy 25Bevacizumab 20Nivolumab 19Epirubicin 19titanium silicide 18Surgical Procedures, Operative 17Carboplatin 17Ramucirumab 16Cetuximab 15Gastrectomy 13apatinib 12Everolimus 12Gemcitabine 11Albumin-Bound Paclitaxel 10Neoadjuvant Therapy 8Folfox protocol 8Drug Therapy 8Chemotherapy, Adjuvant 8Radiation 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Stomach Neoplasms × IFL protocol × Clear all
NCT03597581 2025-04-03

A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer

Inspirna, Inc.

Phase 1 Completed
89 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT02033551 2016-09-27

A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors

AbbVie

Phase 1 Completed
47 enrolled
BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Colonic Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

NCT00313872 2012-01-12

Phase III Trial of DP Followed by FOLFIRI or the Reverse Sequence in Unresectable Gastric Cancer

Samsung Medical Center

Phase 3 Completed
200 enrolled
Gastrointestinal

Neoplasm Metastasis, Stomach Neoplasms

NCT00374036 2011-10-12

Metastatic Gastric Cancer FFCD 03-07

University Hospital, Toulouse

Phase 3 Completed
416 enrolled
Gastrointestinal

Neoplasm Metastasis, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡